Bank of New York Mellon »

Actinium Pharmaceuticals shares owned by Bank of New York Mellon

Quarter-by-quarter ownership of Actinium Pharmaceuticals (ATNM) shares owned by Bank of New York Mellon from 13F filings

Historical chart of Bank of New York Mellon investment in Actinium Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Actinium Pharmaceuticals held by Bank of New York Mellon consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Actinium Pharmaceuticals by Bank of New York Mellon

Quarter filed Position value Share count Share price at filing
2024-03-31 $528k 67k 7.83
2023-12-31 $583k 115k 5.08
2023-09-30 $691k 117k 5.92
2023-06-30 $852k 115k 7.42
2023-03-31 $507k 54k 9.45
2022-12-31 $629k 59k 10.65
2022-09-30 $435k 59k 7.37
2022-06-30 $245k 51k 4.82
2022-03-31 $260k 51k 5.11
2021-12-31 $305k 51k 6.00
2021-09-30 $450k 51k 8.85
2021-06-30 $402k 51k 7.91
2021-03-31 $387k 51k 7.62
2020-12-31 $434k 56k 7.80
2020-09-30 $412k 43k 9.68